Publication - The MoCA

Research has establicshed that the The MoCA is a suitably accurate, brief test when screening all levels of cognition in Parkinson Disease.

Dalrymple-Alford JC, MacAskill MR, Nakas C, Livingston L, Graham CF, Crucian GP, Melzer TR, Kirwan J, Keenan R, Wells S, Porter RJ, Watts R, Anderson TJ. (2010). The MoCA: Well-suited screen for cognitive impairment in Parkinson disease. Neurology. 75:1717-1725.

Read the full text. 

The study was supported by the Neurological Foundation of New Zealand (T.J.A., J.C.D.-A., R.W., R.P., M.R.M., J.K., S.W.), the Canterbury Medical Research Foundation (T.J.A., J.C.D.-A., M.R.M., R.W., R.K.), and the Neurology Trust (T.J.A., L.L.).